By Dr. Erika F. Marie, DACM, LAc | Chiyu Integrative Health | Columbia, SC & Longmont, CO

A Condition That Changes Everything —
And That Conventional Medicine Struggles to Treat

Peripheral neuropathy is damage or dysfunction of the nerves outside the brain and spinal cord, the peripheral nervous system that carries sensory, motor, and autonomic signals throughout the entire body. More than 20 million Americans live with some form of peripheral neuropathy. For many of them, it represents one of the most stubborn, life-limiting conditions they have ever faced.¹

The symptoms are wide-ranging and frequently overlap: burning, tingling, or electric pain in the hands and feet; numbness or loss of sensation; hypersensitivity to touch that makes clothing feel painful; weakness in the legs; balance problems; and autonomic dysfunction including altered sweating, heart rate instability, and digestive disruption. In severe cases, peripheral neuropathy leads to falls, injury, and loss of independence.

The three most common types seen in clinical practice are diabetic peripheral neuropathy (DPN), chemotherapy-induced peripheral neuropathy (CIPN), and idiopathic peripheral neuropathy (where no clear cause is identified despite thorough workup). Each has a somewhat different underlying biology, but all share a final common pathway of damaged, demyelinated, or dysfunctional peripheral nerves.

Conventional treatment is largely symptomatic: gabapentin, pregabalin, duloxetine, and tricyclic antidepressants can reduce pain for some patients, but none of them repair nerves, improve nerve conduction velocity, or reverse the underlying damage. For CIPN specifically, ASCO guidelines acknowledge that no agents are currently recommended for prevention, and only duloxetine, with limited effect, is recommended for established painful CIPN.²

This is where integrative medicine has a genuinely important role to play. Acupuncture, electroacupuncture, dry needling, and Chinese herbal medicine each approach peripheral neuropathy through distinct but complementary biological mechanisms — and the research increasingly shows that these approaches do not merely manage symptoms. Some of them appear to promote actual nerve repair and regeneration.

The Biology of Peripheral Neuropathy: What Is Actually Happening to the Nerves

Understanding the mechanisms of each neuropathy type makes it possible to understand why certain treatments work — and which approach is best suited for each patient.

Diabetic Peripheral Neuropathy (DPN)

DPN is the most common complication of type 2 diabetes, affecting up to 50% of diabetic patients over the course of their illness.³ Chronic hyperglycemia damages peripheral nerves through several converging pathways:

• Advanced glycation end-products (AGEs): excess glucose reacts with proteins to form AGEs that accumulate in nerve tissue, triggering oxidative stress and inflammatory cytokine release

• Polyol pathway activation: excess glucose is converted to sorbitol via aldose reductase, accumulating in Schwann cells and axons, causing osmotic stress, depleting NADPH, and reducing myoinositol — a compound critical for nerve signal conduction

• Mitochondrial dysfunction: hyperglycemia impairs mitochondrial biogenesis in peripheral neurons, reducing ATP production, increasing reactive oxygen species (ROS), and creating a state of bioenergetic exhaustion that causes axonal degeneration

• Schwann cell damage and demyelination: Schwann cells,,the supporting cells that maintain the myelin sheath around peripheral nerve axons, are directly damaged by oxidative stress and apoptotic signals in hyperglycemic conditions, leading to demyelination and slowed or absent nerve conduction

• Reduced neurotrophic support: BDNF, NGF (nerve growth factor), and IGF-1 — the proteins that support peripheral nerve survival, growth, and repair — are significantly reduced in DPN, impairing the nerve's natural capacity for regeneration

Chemotherapy-Induced Peripheral Neuropathy (CIPN)

CIPN affects approximately 68% of patients within the first month of chemotherapy treatment.² The mechanism varies by drug class:

• Platinum-based agents (cisplatin, oxaliplatin, carboplatin): accumulate in dorsal root ganglion neurons via DNA cross-linking, causing direct neuronal damage, mitochondrial dysfunction via oxidative stress, and sensory nerve degeneration. Symptoms typically appear in a stocking-glove distribution

• Taxanes (paclitaxel, docetaxel): disrupt microtubule polymerization and depolymerization dynamics, impairing axonal transport — the mechanism by which nutrients, proteins, and signals travel along the length of the nerve. Without functional axonal transport, nerve fibers degenerate

• Vinca alkaloids (vincristine): also disrupt microtubule function, causing mixed sensory and motor peripheral neuropathy with potential autonomic involvement

Unlike DPN, which is gradual, CIPN symptoms often necessitate dose reduction or cessation of chemotherapy, which directly impacts cancer treatment outcomes. Prevention and early intervention therefore becomes critically important, not just comfort management.

Idiopathic Peripheral Neuropathy

Idiopathic neuropathy — where no identifiable cause is found despite thorough evaluation — is more common than often appreciated, accounting for a substantial proportion of peripheral neuropathy cases. It may involve immune-mediated mechanisms, subclinical metabolic dysfunction, chronic low-grade neuroinflammation, or accumulated toxic exposures that standard testing does not capture. Many patients with "idiopathic" neuropathy later turn out to have identifiable contributors including prediabetes, autoimmune dysregulation, B vitamin deficiencies, thyroid dysfunction, or environmental toxin exposure. For all of these, integrative approaches that address neuroinflammation, microcirculation, oxidative stress, and neurotrophic support remain relevant.

Part One: Acupuncture (Regular/Manual Acupuncture) for Peripheral Neuropathy

Clinical Evidence

Manual acupuncture has been studied in multiple systematic reviews for peripheral neuropathy across all three subtypes.

For painful diabetic peripheral neuropathy, a 2024 systematic review and meta-analysis found that acupuncture produced a statistically significant reduction in pain VAS scores compared to routine care (mean difference −1.45, p<0.0001) and a significantly greater reduction compared to sham acupuncture (mean difference −0.97, p=0.004) — confirming that acupuncture's effect is not simply placebo. Critically, the same meta-analysis found acupuncture significantly improved both sensory nerve conduction velocity (SNCV, MD=2.29, p<0.0001) and motor nerve conduction velocity (MNCV, MD=2.87, p<0.0001) — objective electrophysiological measurements of actual nerve function, not just patient-reported pain.⁴

For CIPN, a randomized controlled pilot trial of 40 breast cancer survivors with taxane-induced neuropathy found that an 8-week acupuncture intervention produced statistically and clinically significant improvements in neuropathic pain, paresthesia, and sensory symptoms compared to usual care — leading researchers to recommend clinicians consider acupuncture for mild to moderate CIPN given the lack of effective conventional alternatives.⁵ A systematic review pooling 386 cancer patients across six RCTs concluded that acupuncture is safe and has meaningful potential in relieving CIPN symptoms.⁶

A landmark crossover RCT — the ACUCIN trial at Hamburg-Eppendorf University Medical Center — was the first study to use nerve conduction studies (NCS) as the primary outcome measure for acupuncture in CIPN. It found that acupuncture enhanced structural nerve regeneration as measured by NCS, with improvements manifested in both objective neurological findings and subjective patient-reported outcomes.⁷

Biochemical Mechanisms of Manual Acupuncture in Neuropathy

• Endogenous opioid and enkephalin release: acupuncture needle stimulation activates A-delta and C nerve fibers, triggering release of beta-endorphin, enkephalin, and endomorphin in the CNS and periphery, reducing pain signal transmission through the dorsal horn and modulating central sensitization⁸

• Serotonergic system activation: in oxaliplatin-induced neuropathy specifically, research has confirmed that acupuncture's efficacy operates through activation of the serotonergic system — particularly spinal 5-HT3 receptors — which modulates pain perception and sensory hypersensitivity in the affected nerve pathways⁶

• Nerve growth factor (NGF) upregulation: electroacupuncture at points Shenshu (BL23) and Zusanli (ST36) increased NGF-positive cells and NGF mRNA expression in the sciatic nerve of diabetic rats — a finding directly relevant to nerve repair and regeneration in DPN. NGF is the primary growth factor for small-fiber sensory neurons, exactly those damaged earliest in peripheral neuropathy⁹

• TNF-α and neuroinflammatory cytokine suppression: acupuncture reduces pro-inflammatory cytokines in the peripheral nervous system and dorsal root ganglia, reducing the neuroinflammatory microenvironment that perpetuates nerve damage and pain signaling¹⁰

• Local microcirculation improvement: acupuncture increases blood flow to acupoints and surrounding nerve tissue — critically important in DPN, where microvascular disease impairs the endoneurial blood supply and creates hypoxic, energy-depleted nerve environments

Part Two: EA: The Most Powerful Needling Intervention for Nerve Repair

Electroacupuncture (EA) involves applying a precisely controlled mild electrical current through acupuncture needles. In the context of peripheral neuropathy, EA is not simply stronger acupuncture. It has distinct and well-characterized neurobiological effects that make it particularly well-suited to nerve repair.

Clinical Evidence: EA Leads the Field for Motor Nerve Conduction

A 2025 Bayesian network meta-analysis — the highest-level evidence methodology available for comparing multiple treatment arms — searched databases from inception through October 2024 and included 62 randomized controlled trials involving 5,942 patients with DPN. The conclusion was unambiguous: electroacupuncture ranked as the most effective acupuncture intervention for improving motor nerve conduction velocity, with a mean difference of 10.65 m/s (95% CI: 4.6–16.7) over control.³

This is not a modest effect. Normal motor nerve conduction velocity is approximately 50–60 m/s; a 10+ m/s improvement represents a clinically meaningful restoration of nerve function — not merely symptom management. A Frontiers in Neurology systematic review and meta-analysis confirmed that acupuncture broadly produces better effective rates than conventional Western medicine alone for DPN.¹¹

A 2025 dose-response meta-analysis of acupuncture for CIPN — searching six databases through August 2024, including 11 RCTs with 740 cancer patients — found that acupuncture significantly improved both pain scores and quality of life in CIPN, and identified optimal treatment parameters: the most significant effects were observed with 8–12 sessions administered 2–3 times per week over 4–6 weeks.¹²

Biochemical Mechanisms: Why EA Is Uniquely Suited to Nerve Repair

• Frequency-specific opioid and neurotransmitter release: as established in the sciatica research, 2 Hz EA primarily releases enkephalin and beta-endorphin (mu/delta opioid receptors); 100 Hz releases dynorphin (kappa receptors); combined frequencies release all four endogenous opioids simultaneously for maximal analgesic effect. In peripheral neuropathy, the 2 Hz/100 Hz combined protocol is most commonly studied and clinically used¹³

• BDNF and NGF upregulation: EA upregulates both brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in the sciatic nerve and dorsal root ganglia — the two most critical trophic factors for peripheral nerve survival and regeneration. In DPN, where both are depleted, this represents a direct biological intervention toward nerve repair, not just symptomatic relief³˒⁹

• Neuregulin 1 (Nrg1) and ErbB2 upregulation: EA increases expression of Nrg1 and its receptor ErbB2 in the sciatic nerve — a signaling pathway directly responsible for Schwann cell differentiation, myelination, and remyelination. This is one of the most compelling mechanisms identified, suggesting EA may actually support the biological process of myelin sheath repair in damaged peripheral nerves¹¹

• Mesenchymal stem cell mobilization: a remarkable finding published in the journal Stem Cells (2017) demonstrated that electroacupuncture promotes CNS-dependent release of mesenchymal stem cells into peripheral circulation — cells with documented ability to support peripheral nerve repair and regeneration. This is a mechanism with no pharmaceutical equivalent and represents a fundamentally regenerative biological response¹⁴

• NMDA receptor modulation and central sensitization reversal: EA modulates NMDA receptor expression in primary sensory neurons, reducing the central sensitization that makes neuropathic pain self-perpetuating and amplified beyond the original nerve injury

• Mitochondrial function support: in DPN specifically, EA has been found to improve mitochondrial bioenergetics in peripheral nerve tissue. This is vital breakthrough reveals that electro-acupuncture directly addresses the mitochondrial dysfunction that underlies axonal degeneration in diabetic neuropathy

Together, the combination of these mechanisms — endogenous analgesia, trophic factor upregulation, Schwann cell support, myelination pathway activation, and stem cell mobilization — explains why EA produces improvements in actual nerve conduction velocity, not merely pain scores. It is exerting biologically regenerative effects, not just analgesic ones.

Part Three: Dry Needling: A Complementary Modality for Neuropathic Pain and Central Sensitization

Dry needling uses the same thin filiform needles as acupuncture but targets myofascial trigger points, peripheral nerve pathways, and sensitized neural tissue. The distinction between dry needling and acupuncture is primarily one of training tradition and clinical model — the tools and neurophysiological effects overlap considerably. In practice, practitioners trained in both can integrate them as complementary components of a neuropathy treatment plan.

Clinical Evidence

A published case report in the Journal of Bodywork and Movement Therapies documented a patient with idiopathic peripheral neuropathy treated with dry needling plus electrical stimulation over four visits. Results included reduction of numeric pain rating scale from 4 to 2, Romberg balance test improvement from 5 seconds to 15 seconds (eyes closed), and sensory testing improvement in L4 and S1 dermatomes from 2/5 to 5/5 correctly identified — suggesting meaningful sensory recovery in just four treatments.¹⁵ The researchers specifically noted this supports adding dry needling with electrical stimulation to the treatment toolkit for this population.

For neuropathic pain associated with postherpetic neuralgia and myofascial components — a condition overlapping with idiopathic nerve pain presentations — a prospective controlled clinical study found ultrasound-guided dry needling for trigger point inactivation produced significantly better VAS and McGill Pain Questionnaire outcomes than pharmacotherapy alone.¹⁶

Biochemical Mechanisms of Dry Needling in Neuropathic Pain

• A-delta fiber activation and opioid-mediated analgesia: needle insertion into trigger points and sensitized tissue stimulates A-delta (group III) sensory afferents for up to 72 hours after treatment, activating enkephalinergic inhibitory interneurons in the dorsal horn and producing opioid-mediated pain suppression without pharmaceuticals¹⁷

• Substance P and CGRP normalization: active myofascial trigger points release substance P, calcitonin gene-related peptide (CGRP), prostaglandins, serotonin, and ATP — nociceptive mediators that sensitize surrounding tissue and the spinal cord. Dry needling inactivates the trigger point and normalizes this pro-nociceptive chemical environment¹⁸

• Sympathetic nervous system calming: dry needling into active trigger points significantly reduces sympathetic skin response amplitude, demonstrating a direct calming effect on the autonomic nervous system, which is particularly relevant in neuropathy with autonomic involvement¹⁹

• NMDA receptor modulation and central sensitization reduction: when electrical stimulation is applied through dry needles (intramuscular electrical stimulation), it modulates NMDA receptor expression in primary sensory neurons, reducing the excitability of dorsal horn neurons that drives neuropathic central sensitization²⁰

• Central pain processing modulation: dry needling of trigger points reduces excitability of the central nervous system by removing a persistent peripheral source of nociception, reducing dorsal horn neuron activity, and modulating pain-related brainstem areas. These effects that extend far beyond the local needle site²¹

Dry needling is most useful in peripheral neuropathy patients who also present with significant myofascial pain, trigger point tenderness, and central sensitization. These patterns are frequently seen in idiopathic neuropathy and CIPN, where the nervous system has become broadly sensitized. It works especially well when combined with electroacupuncture in a single session.

Part Four: Chinese Herbal Medicine for PN: Addressing Root Biology

Chinese herbal medicine represents the most biologically comprehensive approach to peripheral neuropathy in the integrative toolkit. Unlike needling-based therapies — which are powerful for neuromodulation and pain relief — herbal formulas operate at the level of the metabolic, inflammatory, and cellular biology that drives nerve damage. They do not simply modulate pain signals. They target the underlying pathological processes.

Clinical Evidence: Herbal Medicine for DPN

A 2013 meta-analysis of 10 high-quality randomized controlled trials — updated from the Cochrane evidence base — found that Chinese herbal medicine reduced DPN symptoms and improved nerve conduction velocity, with pharmacological research confirming multiple documented mechanisms of action.²²

A 2024 comprehensive review of TCM for DPN — screening PubMed, Cochrane, CNKI, and other databases and analyzing approximately 22 single herbal extracts, more than 30 compound prescriptions, and four patent medicines — identified the core mechanisms by which Chinese herbal medicine benefits DPN: inhibition of inflammation and oxidative stress, reduction of apoptosis, amelioration of endoplasmic reticulum stress, and improvement of mitochondrial function.²³

A retrospective clinical study of 30 patients with moderate-to-severe painful DPN who had failed conventional pharmacotherapy found that a modified classical formula, Huangqi Guizhi Wuwu Decoction (HGWD), administered twice daily for six months produced meaningful clinical improvement in neuropathic pain severity and symptom response. Importantly, blood glucose was maintained throughout, and HGWD was used as an adjunct to — not replacement for — glucose management.²⁴

Huangqi Guizhi Wuwu Decoction (HGWD): The Most Studied Formula for DPN

First recorded in the Han Dynasty classic Synopsis of Prescriptions of the Golden Chamber (3rd century AD), HGWD contains five core herbs: Huangqi (Astragalus), Guizhi (Cinnamon twig), Shaoyao (White peony), Shengjiang (Fresh ginger), and Dazao (Jujube date). This formula has accumulated one of the most detailed modern mechanistic profiles in the peripheral neuropathy literature:

• ROS reduction and antioxidant enzyme upregulation: HGWD reduces reactive oxygen species (ROS) in Schwann cells under hyperglycemic conditions while upregulating total superoxide dismutase (T-SOD) activity. The mechanism operates through PI3K/AKT pathway activation, a central signaling pathway for cell survival and antioxidant defense in neural tissue²³

• Nrf2 pathway activation: HGWD activates the Keap1/Nrf2 pathway (the body's master antioxidant regulator) and upregulates Bcl-2 expression while inhibiting caspase-3, shifting the cellular environment away from apoptosis and toward nerve cell survival and repair²⁴

• Myelin sheath structural preservation: in animal models, HGWD treatment produces more regular myelin sheath morphology, less myelin swelling, more orderly nerve fiber arrangement, and more uniform axonal density. This is direct histological evidence of structural nerve protection²³

• Motor and sensory nerve conduction velocity restoration: the Tang Bi Kang formula derived from HGWD significantly reversed MNCV and SNCV deficits in clinical and preclinical studies, reducing both axonal atrophy and demyelination²³

• Gut microbiome and metabolic pathway improvement: HGWD has been found to ameliorate DPN phenotypes — including sensory threshold and nerve conduction changes, by modifying gut microbiota composition and plasma metabolism, demonstrating the gut-nervous system axis as a mechanism of action²³

• Inflammatory cytokine suppression: TNF-α, IL-6, and COX-2 are downregulated, along with NF-κB. This central inflammatory transcription factor reduces the chronic neuroinflammatory environment in peripheral nerve tissue²³

Schwann Cell Protection: A Unique Advantage of Chinese Herbal Medicine

One of the most compelling findings in Chinese herbal medicine research for neuropathy is the direct protective effect on Schwann cells. Schwann cells are vital, myelin-producing cells. Without them, peripheral nerve function cannot be maintained or restored.

Research published in PMC found that Astragalus (Huangqi), Salvia (Danshen), and Yam used together demonstrated synergistic antiapoptotic action on Schwann cells cultured in hyperglycemic conditions, increasing Bcl-2 expression while inhibiting caspase-3 — and the combination was more effective than any herb individually.²⁵ Separately, the formula Jin Mai Tong reduced inducible nitric oxide synthase (iNOS), NADPH oxidase p22-phox, and active caspase-3 in Schwann cells under high-glucose conditions, reducing oxidative injury and apoptosis.²⁵

This research shows direct interventions in the cellular biology of peripheral nerve maintenance — not just symptom management, but tissue protection at the cellular level.

Chinese Herbal Medicine for CIPN: An Emerging Evidence Base

Research on Chinese herbal medicine for CIPN is less mature than the DPN evidence base but is growing steadily. The biological rationale is clear: herbal formulas that address mitochondrial dysfunction, oxidative stress, neuroinflammation, and trophic factor depletion are mechanistically relevant to the damage caused by the platinum agents and taxanes that operate through those same pathways.

The Xiaoketongbi formula, Danggui Sini decoction, and modifications of HGWD have all been studied in the context of chemotherapy-adjacent neuropathy, with emerging evidence supporting their use as adjuncts to chemotherapy-related care. Clinically, Chinese herbal formulas for CIPN are most often used in the post-chemotherapy recovery period, where the goal shifts from damage prevention to nerve repair and functional restoration.

Part Five: Combining Modalities: The Clinical Rationale for Integration

The four modalities covered in this article address peripheral neuropathy through fundamentally different biological mechanisms. When appropriately combined, they provide a layered intervention that no single approach can match:

• Manual acupuncture: endogenous opioid release, serotonergic analgesia, NGF upregulation, local microcirculation — best for pain relief and sensory symptom reduction

• Electroacupuncture: all of the above plus frequency-specific neuromodulation, BDNF/NGF upregulation, Nrg1/ErbB2 myelination pathway activation, stem cell mobilization — the most powerful option for improving actual nerve conduction velocity and promoting nerve regeneration

• Dry needling: trigger point deactivation, substance P and CGRP normalization, central sensitization reversal, sympathetic calming — most useful when myofascial pain and sensitization are prominent features alongside the neuropathy

• Chinese herbal medicine: Schwann cell protection, mitochondrial repair, Nrf2 antioxidant activation, AGE inhibition, inflammatory cytokine suppression, myelin structural preservation — the only approach that directly addresses the cellular biology of nerve damage and supports structural nerve repair from within

In clinical practice, the most effective outcomes for peripheral neuropathy are typically achieved with electroacupuncture providing the active neuromodulatory and trophic factor-stimulating treatment, combined with a carefully individualized Chinese herbal formula working continuously at the metabolic and cellular level between sessions. Dry needling is added when myofascial central sensitization is a prominent feature. This combination is more biologically comprehensive than any pharmaceutical approach currently available for peripheral neuropathy.

An Evaluation of Where the Research Stands

The evidence for integrative approaches to peripheral neuropathy is among the strongest in the field for DPN and is growing meaningfully for CIPN. The 2025 Bayesian network meta-analysis of 5,942 DPN patients is high-quality, large-scale evidence. The ACUCIN trial's use of nerve conduction studies as primary outcome represents a significant methodological advance for CIPN research.

For idiopathic neuropathy, there is less robust research, though the biological rationale for these interventions is identical to the DPN and CIPN evidence. Larger prospective trials in this population are needed.

The true clinical picture is this: conventional medicine offers symptom management for peripheral neuropathy with no capacity for nerve repair. Integrative approaches — particularly electroacupuncture and Chinese herbal medicine — have documented mechanisms and clinical evidence supporting not just pain reduction, but actual improvement in nerve conduction velocity and cellular-level neuroprotection. For patients whose quality of life is significantly impacted by peripheral neuropathy, these options deserve serious clinical consideration.

Who Might Benefit From an Integrative Peripheral Neuropathy Consultation?

An integrative assessment is well-suited for anyone experiencing:

• Diabetic peripheral neuropathy — whether newly diagnosed or long-standing, painful, or with loss of sensation

• Chemotherapy-induced peripheral neuropathy — during or after treatment, especially where conventional options have been inadequate

• Idiopathic peripheral neuropathy — especially when conventional workup has not identified a treatable cause

• Anyone experiencing burning, tingling, numbness, or electric pain in the hands or feet

• Balance problems, weakness, or reduced sensory perception in the extremities

• Patients seeking options beyond gabapentin, pregabalin, or duloxetine or experiencing unacceptable side effects from those medications

• Those interested in biologically active approaches that support actual nerve repair, not just symptom management

At Chiyu Integrative Health, peripheral neuropathy treatment plans are individualized based on neuropathy type, severity, symptom pattern, medication history, and metabolic context. Chinese herbal formulas are prescribed only after thorough review of all medications. This is very important as several herbs have documented interactions with diabetic medications and chemotherapy agents, and require professional screening.

About the Author

Dr. Erika F. Marie, DACM, LAc is a Doctor of Acupuncture and Chinese Medicine, West Point graduate, and founder of Chiyu Integrative Health in Longmont, Colorado. She is a published researcher in and peer-reviewer for EXPLORE: The Journal of Science and Healing, and consults with patients in-person in Colorado and remotely by phone or video.

Ready to Pursue a More Complete Approach to Your Neuropathy?

Peripheral neuropathy does not have to mean a lifetime of pain management with diminishing returns. A thorough systems-based assessment can identify which combination of integrative approaches best matches your specific type of neuropathy, your biology, and your goals — and create a plan that works alongside whatever conventional care you are already receiving.

Schedule in Longmont, Colorado or by phone or video online at chiyuacupuncture.com.

We also welcome texts and calls at (720) 213-4999.

References

‍1. More than 20 million Americans affected by peripheral neuropathy. National Institute of Neurological Disorders and Stroke. https://www.ninds.nih.gov/health-information/disorders/peripheral-neuropathy

2. ASCO Clinical Practice Guideline: Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers. JCO, 2020. CIPN incidence 68.1% in first month; duloxetine as sole recommended agent. PubMed ID: 32663120. https://pubmed.ncbi.nlm.nih.gov/32663120/

3. Bayesian network meta-analysis: 62 RCTs, 5,942 DPN patients — electroacupuncture most effective for motor NCV (MD 10.65 m/s). PMC12338170. https://pmc.ncbi.nlm.nih.gov/articles/PMC12338170/

4. Acupuncture for painful diabetic peripheral neuropathy: systematic review and meta-analysis — VAS reduction MD −1.45 vs routine care; MD −0.97 vs sham; SNCV MD 2.29 m/s; MNCV MD 2.87 m/s. ScienceDirect, 2024. https://www.sciencedirect.com/science/article/pii/S1744388124000628

5. Acupuncture for CIPN in breast cancer survivors: RCT of 40 patients with taxane-induced neuropathy — significant improvement in neuropathic pain and paresthesia vs usual care over 8 weeks. PubMed ID: 32297442. https://pubmed.ncbi.nlm.nih.gov/32297442/

6. Efficacy of acupuncture in CIPN: systematic review and meta-analysis — 386 cancer patients, 6 RCTs; safe with meaningful symptom potential; oxaliplatin mechanism via serotonergic/5-HT3 activation. PMC7242803. https://pmc.ncbi.nlm.nih.gov/articles/PMC7242803/

7. ACUCIN trial: acupuncture for CIPN with nerve conduction studies as primary outcome — demonstrates structural nerve regeneration measurable by NCS. ScienceDirect, 2022. https://www.sciencedirect.com/science/article/pii/S0944711322003737

8. Acupuncture analgesia: endogenous opioid mechanisms, A-delta fiber activation, beta-endorphin, enkephalin, dynorphin — naloxone blockade confirms opioid mediation. PubMed ID: 15135942. https://pubmed.ncbi.nlm.nih.gov/15135942/

9. EA at BL23/ST36 upregulates NGF-positive cells and NGF mRNA in sciatic nerve of diabetic rats — direct evidence for nerve repair mechanism. Reviewed in: PMC3426291. https://pmc.ncbi.nlm.nih.gov/articles/PMC3426291/

10. Cytokine changes after electroacupuncture in neuropathic rats — TNF-α reduction and neuroinflammatory modulation. Evidence-Based Complementary and Alternative Medicine, 2012. As cited in: Perineural Electrical Dry Needling for CIPN review. https://spinalmanipulation.org/wp-content/uploads/2025/03/perineural-electrical-dry-needling-for-chemotherapy-induced-peripheral-neuropathy-2025.pdf

11. Efficacy of acupuncture for DPN: systematic review and meta-analysis — better effective rate than conventional Western medicine alone; Nrg1/ErbB2 myelination pathway upregulation by EA. Frontiers in Neurology, 2024. https://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2024.1500709/full

12. Dose-response meta-analysis of acupuncture for CIPN: 11 RCTs, 740 patients — optimal 8–12 sessions at 2–3x/week over 4–6 weeks; significant pain and QoL improvement. PMC11873836. https://pmc.ncbi.nlm.nih.gov/articles/PMC11873836/

13. Frequency-dependent opioid release in electroacupuncture: 2 Hz (enkephalin/beta-endorphin), 100 Hz (dynorphin), combined maximum effect. PubMed ID: 18711761. https://pubmed.ncbi.nlm.nih.gov/18711761/

14. Electroacupuncture promotes CNS-dependent release of mesenchymal stem cells into peripheral circulation. Stem Cells, 2017. Salazar TE et al. As cited in: Perineural Electrical Dry Needling for CIPN, JCM 2025. https://spinalmanipulation.org/wp-content/uploads/2025/03/perineural-electrical-dry-needling-for-chemotherapy-induced-peripheral-neuropathy-2025.pdf

15. Dry needling with electrical stimulation for idiopathic peripheral neuropathy — pain reduction, Romberg balance improvement, L4/S1 sensory recovery in 4 treatments. PubMed ID: 31103112. https://pubmed.ncbi.nlm.nih.gov/31103112/

16. Ultrasound-guided dry needling for postherpetic neuralgia with myofascial pain syndrome — superior VAS and MPQ outcomes vs pharmacotherapy alone. PubMed ID: 35958677. https://pubmed.ncbi.nlm.nih.gov/35958677/

17. A-delta fiber stimulation by dry needling activates enkephalinergic dorsal horn interneurons — opioid-mediated analgesia via superficial dry needling for up to 72 hours. PMC4458928. https://pmc.ncbi.nlm.nih.gov/articles/PMC4458928/

18. Substance P, CGRP, prostaglandins, 5-HT, ATP released from trigger points — dry needling normalizes pro-nociceptive chemical environment. PMC9159711. https://pmc.ncbi.nlm.nih.gov/articles/PMC9159711/

19. Dry needling into active trigger points reduces sympathetic skin response amplitude and motor endplate irritability. PubMed ID: 27697768. https://pubmed.ncbi.nlm.nih.gov/27697768/

20. NMDA receptor modulation by intramuscular electrical stimulation through dry needles — reduces central sensitization in dorsal horn. PMC3625794. https://pmc.ncbi.nlm.nih.gov/articles/PMC3625794/

21. Trigger point dry needling reduces CNS excitability, dorsal horn neuron activity, and brainstem pain-related areas. PubMed ID: 31354339. https://pubmed.ncbi.nlm.nih.gov/31354339/

22. Chinese herbal medicine for DPN: meta-analysis of 10 high-quality RCTs — improved NCV and symptoms; mechanisms include BDNF/NGF upregulation, oxidative stress reduction, AGE inhibition, cytokine reduction. PubMed ID: 24146822. https://pubmed.ncbi.nlm.nih.gov/24146822/

23. Advances of TCM in DPN: comprehensive 2024 review — 22 single herbs, 30+ compound formulas, 4 patent medicines; mechanisms: PI3K/AKT, Keap1/Nrf2, AMPK/PGC-1α, NF-κB, endoplasmic reticulum stress, mitochondrial function, myelin preservation. PubMed ID: 38946248. https://pubmed.ncbi.nlm.nih.gov/38946248/

24. Modified HGWD in moderate-severe painful DPN refractory to conventional pharmacotherapy: 6-month retrospective study — Nrf2/Bcl2 pathway mechanism. PMC6948321. https://pmc.ncbi.nlm.nih.gov/articles/PMC6948321/

25. Astragalus, Salvia, and Yam — synergistic antiapoptotic protection of Schwann cells under hyperglycemia; Bcl-2 upregulation, caspase-3 inhibition; Jinmaitong reduces iNOS/NADPH oxidase/caspase-3 in Schwann cells. PMC3426291. https://pmc.ncbi.nlm.nih.gov/articles/PMC3426291/

Disclaimer: This article is for educational purposes only and does not constitute medical advice or a diagnosis. If you are currently receiving chemotherapy, consult your oncologist before beginning any herbal or integrative therapy. Chinese herbal formulas should only be prescribed by a formally trained practitioner after review of all current medications. Always consult with a qualified healthcare provider regarding your individual health situation.